Predicted Trait | |
Reported Trait | LDL cholesterol |
Mapped Trait(s) | low density lipoprotein cholesterol measurement (EFO_0004611) |
Score Construction | |
PGS Name | wGRS |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | NR |
Variants | |
Original Genome Build | NR |
Number of Variants | 10 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000421 |
Citation (link to publication) | Wang J et al. Arterioscler Thromb Vasc Biol (2016) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 19,840 individuals (100%) |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST000287 Europe PMC: 19060906 |
19,840 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM017043 | PSS010103| Multi-ancestry (including European)| 313 individuals |
PGP000421 | Wang J et al. Arterioscler Thromb Vasc Biol (2016) |
Reported Trait: FH mutation-negative with severe hypercholesterolemia | OR: 3.02 [1.61, 5.68] | — | — | — | — |
PPM017047 | PSS010104| European Ancestry| 89,528 individuals |
PGP000422 | Vanhoye X et al. Transl Res (2022) |Ext. |
Reported Trait: LDL-c blood concentration | β: 0.16 [0.15, 0.16] | AUROC: 0.6072 [0.6, 0.614] | R²: 0.09317 | Age, BMI, sex, age | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010103 | — | — | 313 individuals, 41.5 % Male samples |
Mean = 51.0 years | South Asian, European, African unspecified, NR | South Asian, European, African, NR | NR | Ontario hypercholesterolemia cohort |
PSS010104 | — | — | 89,528 individuals | — | European | — | UKB | — |